P002
IMMUNE CHECKPOINT EXPRESSION ON TUMOR INFILTRATING LYMPHOCYTES (TIL) IS DEPENDENT ON HPV STATUS IN OROPHARYNGEAL CARCINOMA (OPSCC) - A SINGLE CELL RNA SEQUENCING ANALYSIS
Cancer Biology
A. von Witzleben1; A. Grages1; T. A. Kors1; J. Thomas2; E. V. King3; J. Eziç1; C. Brunner1; P. J. Schuler1; J. Kraus4; H. Kestler4; J. Doescher1; C. Ottensmeier5; T. K. Hoffmann1; S. Laban1
1Department of Otorhinolaryngology and Head & Neck Surgery, Ulm, Germany; 2Faculty of Medicine, Cancer Sciences Unit, Southampton, UK; 3Department of Otorhinolaryngology and Head & Neck Surgery, Poole Hospital, Poole, UK; 4Institute for Medical Systems Biology, Ulm, Germany; 5Department of Molecular & Clinical Cancer Medicine, University of Liverpool, UK
P003
THE GENETIC LANDSCAPE OF HEAD AND NECK CANCER USING BRUSH BIOPSY
Evit John, BDS, MPH, PhD, Candidate1; Xiao Zhao, MD, PHD1; Peter Van Loo, PHD1; Tom Lesluyes, PHD2; Toby Baker, PhD Candidate2
1MD Anderson Cancer Center; 2The Francis Crick Institute
P004
AUTOMATED MACHINE LEARNING-BASED CLASSIFICATION CORRESPONDS TO PATHOLOGIST CLASSIFICATION OF HEAD AND NECK CANCER PATIENT DERIVED ORGANOID MORPHOLOGY
Anuraag S Parikh, MD1; Andres Klein-Szanto, MD, PhD2; Daria Vasilyeva, DDS1; Ogoegbunam Okolo, BS1; Victoria X Yu, MD1; Samuel P Flashner, PhD1; Cecilia Martin, BS1; Masataka Shimonosono, PhD1; Salvatore M Caruana, MD1; Scott H Troob, MD1; Angela J Yoon, DDS3; Devraj Basu, MD, PhD4; Fatemeh Momen-Heravi, DDS, PhD1; Hiroshi Nakagawa, MD, PhD1
1Columbia University; 2Fox Chase Cancer Center; 3Medical University of South Carolina; 4University of Pennsylvania
P005
EFFECT OF EPHEDRA SINICA EXTRACT ON THE SENSITIVITY OF RADIOTHERAPY IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
Young-Gyu Eun; Hee Jin Kang; Su Il Kim; Young Chan Lee
Kyung Hee University
P006
DIFFERENTIAL EXPRESSION OF MMP-2 AND MMP-9 ON ORAL SQUAMOUS CELL CARCINOMA (OSCC) SUBSITES AND THEIR CLINICAL SIGNIFICANCE
S. Lynn Sigurdson, PhD; Subin Surendran, PhD; William J Magner, PhD; Moni A Kuriakose, MD; Wesley L Hicks, Jr., DDS, MD
Roswell Park Comprehensive Cancer Center, Buffalo NY
P007
EFFICACY OF DEPATUXIZUMAB MAFODTIN (ABT-414) IN EGFR-EXPRESSING HEAD AND NECK CANCER
Lucas D Mani1; Guolan Lu, PhD2; Marisa Hom, PhD1; Abdullah Naveed, MD1; Eben Rosenthal, MD1
1Vanderbilt University Medical Center; 2Stanford University
P010
EXPLORING THE ROLE OF SENESCENCE IN ORAL CARCINOGENESIS
Jessica Bourbonnais, MSc1; Francis Rodier, PhD1; Apostolos Christopoulos, MD, MSc2
1Institut du Cancer de Montréal, CRCHUM; 2CHUM
P011
5-AZACYTIDINE PROMOTES IMMUNE RECOGNITION AND T CELL INFILTRATION IN HPV-POSITIVE HEAD AND NECK SQUAMOUS CELL CARCINOMA PATIENTS
Jason Tasoulas, MD, DMD1; Andrew Sewell, MD, PhD1; Hina Rehmani, PhD1; David Rimm, MD, PhD2; Karen S Anderson, PhD2; Barbara Burtness, MD2; Wendell G Yarbrough, MD, MMHC, FACS1; Natalia Issaeva, PhD1
1University of North Carolina at Chapel Hill; 2Yale University
P013
PROGNOSTIC FACTORS IN OLIGOMETASTATIC DISEASE: A PAN-CANCER SYSTEMATIC REVIEW AND META-ANALYSIS
Yiu Tsun Kwan, MBBS; Chong Boon Teo, MBBS; Kai Xun Joshua Tay, MBBS, PHD
NUHS
P014
THE IMPLICATIONS OF MICROBIOME DIFFERENCES IN HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
Tomasz Zatonski, Prof
Wroclaw Medical University, ENT H&N Surgery Dep.
AHNS 11th International Conference on
Head and Neck Cancer
July 8-12, 2023
Palais des congrès de Montréal
Montréal, QC